Shenzhen Yilifang biotechnology Co., ltd.
Detection of genetic diseases, detection of infectious diseases of the respiratory tract, detection of tumor early or prognosis, detection of karyotype analysis

New products

Yilifang meters of biological long-term focus on re technology research and development, promote the transformation of scientific and technological achievements with an open mind, and enhance the ability of scientific and technological value creation. Now it has a large number of high-quality technical professionals, including nearly 10 doctors and masters, with strong technical force and advanced development ability. In the face of long-term and sudden public health problems, we continue to strive to develop all kinds of the latest and most comprehensive products.

Birth Defect Detection

China is a large populated country with a high incidence of birth defects. According to the "China Birth Defects Prevention Report (2012)" released by the former Ministry of Health in September 2012, the current incidence of birth defects in China is about 5.6%, and there are about 900,000 new birth defects each year. Among them, there are about 250,000 birth defects that are clinically visible at birth. "Early detection, early prevention, early treatment" is the guiding principle of the prevention and treatment of birth defects. The purpose of carrying out genetic testing is to prevent birth defects from the source. We launched a series of products in the context of the new era to achieve: high science, high coverage, high suitability, high accuracy, high quality, and high cost-effective.

Respiratory Infections

The detection of respiratory pathogens is one of the main production lines of Ecuador. The company was aware of the harmfulness and urgency of the disease society at the beginning of the company's establishment, and organized several major technical breakthroughs and double-chain fusion project declarations. After several years of intensive cultivation, respiratory infection detection has formed a systematic product layout and established a core technology platform. Currently, it has developed detection kits for more than 20 common respiratory pathogens, and also developed POCT rapid detection and accurate Nucleic acid detection, multi-target detection and single-target detection, better complement each other, to achieve the best clinical use and public health prevention and control.

Tumor Detection

Tumors are a genomic disease. The occurrence of tumors begins with genetic mutations, and genetic testing is the personalized treatment of tumors—a new era of precision medicine. Precision medicine is the latest medical model developed on the basis of data from the Human Genome Project and the results of evidence-based medicine. Sex and effectiveness, to avoid adverse reactions, is the most cutting-edge clinical practice model.

Cytogenetics (karyotyping)

The chromosome karyotype analysis is to analyze the characteristics of chromosome length, centromere position, arm ratio, satellite size, etc. in the cells of the organism. After the karyotype analysis, the cause of the organism can be judged based on the variation of the chromosome structure and number, such as the disease caused by what kind of gene is missing. The major clinically relevant diseases for this test are: male Turner syndrome, mental disorders associated with chromosomal abnormalities, mixed ovarian mixed germ cell-sexual interstitial tumors, congenital ovarian hypoplasia in children, and meow syndrome in children. Signs, pediatric androgen insensitivity syndrome, pediatric androgenic deformity, pediatric Edwards syndrome, myelodysplastic syndrome, myoclonic cerebellar coordination disorder and so on.

Biochemical Reagents

Our company always adheres to the goal of providing customers with suitable products. Under the premise of developing a series of core technology diagnostic reagents, in order to cooperate with customers to better work and enable customers to carry out work appropriately and easily, we have also developed a series of cost-effective and high-quality Biochemical reagents to choose from.

Equipment

Under the premise of developing a series of diagnostic reagents with core technology, our company independently develops and manufactures corresponding instruments and equipment to assist clinical judgment.